Alabama Senate Bill 239
Session 2023rs
Relating to Opioid Addiction Treatment; to repeal the Medication Assisted Treatment of Opioid Use Act of 2019, codified as Sections 20-2-300 through 20-2-302, Code of Alabama 1975, that provide for adoption of rules governing use of buprenorphine in the treatment of opioid addiction and a standing working group to assist in drafting the rules.
Became Law
Became Law on Jun 1, 2023
Origin Chamber
Senate
Type
Bill
Bill Number
239
State
Alabama
Session
2023rs
checkPassed on May 3, 2023
Motion Text
Roll of the S for Vote 552 on SB239 (2023 Regular Session)
Senate Roll Call Votes
Yes
Yes
Yes
Yes
Yes
Yes
Didn't Vote
Didn't Vote
Yes
Yes
Didn't Vote
Didn't Vote
Yes
Yes
Yes
Yes
Yes
Yes
Didn't Vote
Didn't Vote
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Didn't Vote
Didn't Vote
Summary
Medication Assisted Treatment of Opioid Use Act, repealed
Fiscal Note: As Passed First Chamber
Fiscal Note: As Introduced
Sort by most recent
06/01/2023
Office of the Governor
Enacted as 2023-339
05/18/2023
House
On Third Reading in Second House
05/18/2023
House
Read a Third Time and Pass
05/18/2023
House
Ready to Enroll
05/18/2023
Senate
Enrolled
05/11/2023
House
Read Second Time in Second House
05/10/2023
House
Reported Favorably (Health)
05/10/2023
House
Reported Out of Committee in Second House
05/04/2023
Senate
Read First Time in Second House
05/04/2023
House
Referred to Committee (Health)
05/03/2023
Senate
On Third Reading in House of Origin
05/03/2023
Senate
Read a Third Time and Pass
05/03/2023
Senate
Read a Third Time and Pass
04/27/2023
Senate
Read Second Time in House of Origin
04/26/2023
Senate
Reported Favorably (Healthcare)
04/26/2023
Senate
Reported Out of Committee in House of Origin
04/25/2023
Senate
Read First Time in House of Origin
04/25/2023
Senate
Introduced and Referred (Healthcare)
Sources
AL Legislature
Record Created
Apr 25, 2023 11:37:20 PM
Record Updated
Jun 2, 2023 5:13:28 PM